The global Diabetes Care Devices market was valued at USD...
Read MoreThe global Robotic Endoscopy Devices market was valued at USD 2.6 billion in 2025 and is projected to reach USD 6.0 billion by 2035, advancing at an exceptional CAGR of 9.7%. The market encompasses diagnostic robotic endoscopy devices (robotic diagnostic endoscopes, robotic capsule endoscopy systems, robotic navigation endoscopy systems) and therapeutic robotic endoscopy devices (robotic endoscopic surgery systems, resection systems, suturing and closure systems, biopsy systems, ablation systems). By procedure type: diagnostic, therapeutic, image-guided, and minimally invasive surgical procedures. By application: laparoscopy, bronchoscopy, colonoscopy, upper GI endoscopy, urology, gynaecology, ENT, and neurosurgery. By technology: master-slave robotic systems, magnetically controlled robotic systems, capsule robotic endoscopy, flexible robotic endoscopy systems, AI-assisted robotic endoscopy, and autonomous/semi-autonomous systems. By component: robotic platform, arms, console, navigation system, visualisation system (HD/3D/4K), accessories and instruments, and software and navigation modules. End users: hospitals, ASCs, outpatient facilities, specialty endoscopy centres, and academic and research institutes.
The robotic endoscopy devices market is experiencing exceptional growth at 9.7% CAGR from the convergence of robotic technology with two major endoscopy domains: the commercial deployment of AI-assisted robotic systems for automated polyp detection during colonoscopy — demonstrably improving adenoma detection rates above standard colonoscopy — and the clinical development of flexible robotic bronchoscopy platforms for navigated peripheral lung lesion biopsy that overcomes the fundamental limitation of conventional flexible bronchoscopy in reaching small peripheral pulmonary nodules through tortuous distal bronchial anatomy.
How are AI-assisted robotic colonoscopy systems improving adenoma detection above standard colonoscopy?
Computer-aided detection (CADe) systems that analyse real-time colonoscopy video frames using deep learning object detection algorithms and generate immediate visual alerts to the endoscopist when a polyp-like lesion is identified in the field of view have been evaluated in multiple large randomised controlled trials demonstrating statistically significant adenoma detection rate improvement above standard unassisted colonoscopy, particularly for diminutive and flat polyps below 5 mm in diameter that carry the highest endoscopist miss rates. Meta-analyses aggregating AI-CADe colonoscopy trial data confirm a pooled adenoma detection rate improvement of approximately 10 to 15 absolute percentage points, sustaining commercial deployment of AI-CADe modules as standard of care enhancements at colonoscopy quality-focused programmes.
How do robotic bronchoscopy platforms overcome the peripheral pulmonary nodule biopsy limitation of conventional bronchoscopy?
Robotic bronchoscopy systems — including the Intuitive Ion and Auris Monarch robotic bronchoscope platforms — deliver a steerable robotic catheter with integrated vision and ultrasound or CT-fluoroscopy-based navigation guidance through bronchial airways to sub-segment positions adjacent to peripheral pulmonary nodules below 20 mm in diameter that conventional flexible bronchoscopes cannot reliably navigate. The robotic catheter’s ability to make simultaneous roll, pitch, and yaw movements with constant luminal vision enables navigation to bronchi that human wrist torque applied to a conventional bronchoscope cannot achieve, improving the bronchoscopic biopsy yield for CT-screen-detected peripheral lung lesions above the 30 to 50 percent yield ceiling of standard guided bronchoscopy.
How is magnetically controlled robotic capsule endoscopy advancing above conventional wireless capsule endoscopy?
Magnetically controlled robotic capsule endoscopes — navigated through the GI lumen using external magnet systems controlled by the examining physician from outside the patient body — provide active steering capability that allows the physician to direct the capsule’s view toward mucosal areas of clinical interest, hold the capsule in position for extended mucosal examination, and retroflect to visualise the proximal gastric fundus that passively tumbling conventional wireless capsules rarely image adequately. Magnetically guided capsule gastroscopy has been evaluated as an alternative to conventional upper GI endoscopy in anxiety-averse and unsedated patients, with published feasibility data supporting diagnostic equivalence in cooperative patients.
What is driving therapeutic robotic endoscopy adoption in complex GI procedures?
Therapeutic robotic endoscopy systems providing bimanual instrument control through robotic arms introduced through the working channels of therapeutic endoscopes enable precise tissue manipulation in endoscopic submucosal dissection, endoscopic closure of GI perforations and defects, and per-oral endoscopic myotomy procedures that require the equivalent of two-handed technique that single-instrument conventional endoscopy cannot achieve with comparable precision. Robotic ESD systems maintaining continuous tissue traction while the cutting instrument operates in the submucosal plane dramatically reduce the technical complexity of this demanding procedure, sustaining investment in robotic therapeutic endoscopy despite the significant capital cost of dedicated robotic endoscopy platforms.
What clinical performance advantages do robotic flexible endoscopy systems provide in ERCP?
Robotic catheter systems for ERCP biliary cannulation — providing physician-controlled deflection and rotation of the catheter tip through a robotic handle rather than manual guidewire torque at the endoscope working channel — reduce failed biliary cannulation rates in difficult papilla anatomy cases where conventional guidewire technique is associated with post-ERCP pancreatitis from repeated unsuccessful cannulation attempts. Robotic ERCP catheter systems are evaluated at advanced endoscopy centres managing high volumes of difficult biliary access cases including surgically altered anatomy and periampullary diverticulum that create conventional cannulation technical challenges.
Which robotic endoscopy segments are growing fastest?
AI-CADe colonoscopy system deployment as standard of care enhancement across colonoscopy quality-focused programmes, robotic bronchoscopy peripheral lung nodule biopsy adoption from CT screening programme growth, magnetically controlled capsule endoscopy advancing gastric examination above conventional passive capsule, and therapeutic robotic ESD systems reducing procedural complexity for advanced GI neoplasia resection are the four fastest-growing segments.
Key Players: Intuitive Surgical (Ion Robotic Bronchoscopy), Johnson & Johnson (Monarch/Auris), Medtronic (Hugo Robot), Olympus (EndoBRAIN AI, Endoscopy AI), Fujifilm (CAD EYE AI Colonoscopy), AI Medical Service (Gastrointestinal AI), Endomag (AI Localization), Activ Surgical, Motus GI Holdings (Pure-Vu), Endorobotics (Robotic Colonoscopy), Endomagnetics, Magnetically Controlled Endoscopy, Aesthetics and Advanced Endoscopy, Pentax Medical (AI Integration), Boston Scientific (Robotic Endoscopy), EndoGastric Solutions, Apollo Endosurgery (Robotic Bariatric), Stryker (Robotic Integration)
The Robotic Endoscopy Devices market exceptional trajectory toward USD 6.0 billion by 2035 at 9.7% CAGR reflects the convergence of AI-CADe colonoscopy RCT evidence sustaining commercial deployment, robotic bronchoscopy peripheral lung biopsy adoption, and therapeutic robotic endoscopy advancing complex GI procedure capability. Olympus EndoBRAIN AI colonoscopy commercial launch, Intuitive Surgical Ion robotic bronchoscopy registry yield data, and Fujifilm CAD EYE dual CADe/CADx European commercialisation confirm the robotic endoscopy devices market will sustain exceptional above-sector growth through 2035.
Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.
The global Diabetes Care Devices market was valued at USD...
Read MoreThe global Dialysis Equipment market was valued at USD 6.1...
Read MoreThe global In Vitro Diagnostic Devices market was valued at...
Read MoreWhatsApp us